Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04926285
Title Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia
Acronym VEN-OM
Recruitment Recruiting
Gender
Phase Phase I
Variant Requirements No
Sponsors University of Illinois at Chicago
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.